Literature DB >> 11353572

New trends in the treatment of orthostatic hypotension.

J Jordan1.   

Abstract

Nonpharmacologic and pharmacologic treatment can significantly attenuate the symptoms of orthostatic hypotension. Some of the interventions that are used to treat orthostatic hypotension have been known for decades. However, several new treatment strategies have been developed in recent years. New knowledge about the pathophysiology of orthostatic syndromes has been gathered that will strongly influence the way treatments are tailored to individual patients. For example, patients with and without residual autonomic function exhibit differential responses to certain treatments. A large subgroup of patients with severe autonomic failure show a profound pressor response to water drinking. This simple effect can be exploited to treat orthostatic and postprandial hypotension in some patients. New bioengineering technologies that attempt to replicate normal baroreflex mechanisms may become available for selected patients with central autonomic dysfunction.

Entities:  

Mesh:

Year:  2001        PMID: 11353572     DOI: 10.1007/s11906-001-0041-7

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  54 in total

1.  Unmyelinated nerve fibers in sural nerve in pure autonomic failure.

Authors:  T Kanda; H Tomimitsu; T Yokota; N Ohkoshi; M Hayashi; H Mizusawa
Journal:  Ann Neurol       Date:  1998-02       Impact factor: 10.422

2.  Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension.

Authors:  J Möhring; K Glänzer; J A Maciel; R Düsing; H J Kramer; R Arbogast; J Koch-Weser
Journal:  J Cardiovasc Pharmacol       Date:  1980 Jul-Aug       Impact factor: 3.105

Review 3.  Pathophysiological basis of orthostatic hypotension in autonomic failure.

Authors:  A A Smit; J R Halliwill; P A Low; W Wieling
Journal:  J Physiol       Date:  1999-08-15       Impact factor: 5.182

4.  Sympathetically mediated hypertension in autonomic failure.

Authors:  J R Shannon; J Jordan; A Diedrich; B Pohar; B K Black; D Robertson; I Biaggioni
Journal:  Circulation       Date:  2000-06-13       Impact factor: 29.690

5.  Novel therapeutic strategy against central baroreflex failure: a bionic baroreflex system.

Authors:  T Sato; T Kawada; T Shishido; M Sugimachi; J Alexander; K Sunagawa
Journal:  Circulation       Date:  1999-07-20       Impact factor: 29.690

6.  Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension.

Authors:  J Onrot; M R Goldberg; I Biaggioni; A S Hollister; D Kingaid; D Robertson
Journal:  N Engl J Med       Date:  1985-08-29       Impact factor: 91.245

7.  Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.

Authors:  F M Fouad-Tarazi; M Okabe; H Goren
Journal:  Am J Med       Date:  1995-12       Impact factor: 4.965

8.  Basis of nocturnal polyuria in patients with autonomic failure.

Authors:  C S Wilcox; M J Aminoff; W Penn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-06       Impact factor: 10.154

9.  The diagnosis and treatment of baroreflex failure.

Authors:  D Robertson; A S Hollister; I Biaggioni; J L Netterville; R Mosqueda-Garcia; R M Robertson
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

10.  Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin.

Authors:  M S Kochar; H D Itskovitz
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.